Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Leung

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Plos Medicine|December 5, 2008
Ovarian carcinoma subtypes are different diseases: implications for biomarker studiesMartin Köbel, Steve E Kalloger, Niki Boyd, et al.
Gynecologic Oncology|April 26, 2020
Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratificationSoyoun Rachel Kim, Basile Tessier Cloutier, Samuel Leung, et al.
Plos One|April 21, 2016
Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect CorrectionAline Talhouk, Stefan Kommoss, Robertson Mackenzie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2012
A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifenStephen K Chia, Vivien H Bramwell, Dongsheng Tu, et al.
Cell Metabolism|September 15, 2015
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast CancerFanny Dupuy, Sébastien Tabariès, Sylvia Andrzejewski, et al.
Histopathology|January 15, 2025
Prognostic values of molecular subtypes and SWI/SNF protein expression in de-differentiated/undifferentiated endometrial carcinomaChae Young Shin, Bengul Gokbayrak, Valerie L Tao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2010
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancerTorsten O Nielsen, Joel S Parker, Samuel Leung, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
The Journal of Pathology|April 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinomaSpencer D Martin, Shelby Thornton, Christine Chow, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2009
Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancerCarrie R Graveel, Jack D DeGroot, Yanli Su, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Plos Medicine|December 5, 2008
Ovarian carcinoma subtypes are different diseases: implications for biomarker studiesMartin Köbel, Steve E Kalloger, Niki Boyd, et al.
Gynecologic Oncology|April 26, 2020
Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratificationSoyoun Rachel Kim, Basile Tessier Cloutier, Samuel Leung, et al.
Plos One|April 21, 2016
Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect CorrectionAline Talhouk, Stefan Kommoss, Robertson Mackenzie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2012
A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifenStephen K Chia, Vivien H Bramwell, Dongsheng Tu, et al.
Cell Metabolism|September 15, 2015
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast CancerFanny Dupuy, Sébastien Tabariès, Sylvia Andrzejewski, et al.
Histopathology|January 15, 2025
Prognostic values of molecular subtypes and SWI/SNF protein expression in de-differentiated/undifferentiated endometrial carcinomaChae Young Shin, Bengul Gokbayrak, Valerie L Tao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2010
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancerTorsten O Nielsen, Joel S Parker, Samuel Leung, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
The Journal of Pathology|April 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinomaSpencer D Martin, Shelby Thornton, Christine Chow, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2009
Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancerCarrie R Graveel, Jack D DeGroot, Yanli Su, et al.
Pageof 13